Form 8-K - Current report:
SEC Accession No. 0001079973-25-000735
Filing Date
2025-05-01
Accepted
2025-05-01 16:21:29
Documents
15
Period of Report
2025-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 29704
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 9156
  Complete submission text file 0001079973-25-000735.txt   259070

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE scpx-20250430.xsd EX-101.SCH 3548
4 XBRL DEFINITION FILE scpx-20250430_def.xml EX-101.DEF 26578
5 XBRL LABEL FILE scpx-20250430_lab.xml EX-101.LAB 36526
6 XBRL PRESENTATION FILE scpx-20250430_pre.xml EX-101.PRE 25202
17 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5522
Mailing Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 2 SAN ANTONIO TX 78205 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25903460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)